• Health Care Enforcement Review and 2017 Outlook: Part 2
  • March 13, 2017 | Authors: Laurence J. Freedman; Samantha P. Kingsbury; Karen S. Lovitch
  • Law Firm: Mintz Levin Cohn Ferris Glovsky Popeo P.C. - Boston Office
  • Law360, New York (January 17, 2017, 11:21 AM EST) - In part 1 of this four-part series, we examined the U.S. Food and Drug Administration's wide-ranging enforcement activities related to health care fraud. Here, part 2 will discuss 2016's major case developments in health care enforcement.